Epigenetic regulation of nutrient sensing in the prostate
前列腺营养感应的表观遗传调控
基本信息
- 批准号:BB/D523651/1
- 负责人:
- 金额:$ 36.42万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2006
- 资助国家:英国
- 起止时间:2006 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
It is clear that a broad diet, with plenty of fresh fruit and vegetables is required for growth as a child and health as an adult. Surprisingly little is really understood of how many of these food substances help the body to stay healthy. A family of proteins in human cells, called nuclear receptors, bind to small substances, which are part of a healthy diet, such as vitamins. Each receptor acts like a lock, and binds to a specific substance or group of closely related ones, like a key. These receptors are attached to specific genes inside cells, and when the correct key is in the lock it is able to unfold a gene and allow it to be turned on. The gene then makes a protein which controls how the cell grows and dies. This unfolding is known as epigenetics and is very tightly controlled because not every cell needs every gene to function correctly. This is important because it has become clear that even in adults the body still grows. To keep size constant the body controls the rate at which cells grow, divide and die, with those that die being replaced by new ones. This depends on the correct genes being unfolded at the right time and others being kept locked away. Sometimes in old age or during cancer these controls are lost and lead to problems. In men for example this can affect how the size of one gland, the prostate, is controlled. The understanding that food signals can bind to specific receptors and control the function of cells is important and this grant will analyse the direct mechanisms by which these nutrient signals are sensed, often balanced with other signals, and act to unfold specific gene targets. This will help other scientists to understand what is important in a healthy diet and help people of all ages to be more healthy and live longer.
很明显,广泛的饮食,包括大量的新鲜水果和蔬菜,是儿童成长和成人健康所必需的。令人惊讶的是,人们对这些食物中有多少能帮助身体保持健康知之甚少。人类细胞中有一种叫做核受体的蛋白质家族,它与维生素等健康饮食中的小物质结合。每个受体的作用就像一把锁,与一种特定的物质或一组密切相关的物质结合,就像一把钥匙。这些受体附着在细胞内的特定基因上,当正确的钥匙在锁上时,它就能打开一个基因,并允许它被打开。然后,该基因产生一种蛋白质,控制细胞的生长和死亡。这种展开被称为表观遗传学,它受到非常严格的控制,因为不是每个细胞都需要每个基因才能正常工作。这一点很重要,因为很明显,即使是成年人,身体仍在生长。为了保持大小不变,身体控制细胞生长、分裂和死亡的速度,死亡的细胞被新的细胞所取代。这取决于正确的基因在正确的时间展开,而其他基因则被锁起来。有时在老年或癌症期间,这些控制失去并导致问题。例如,在男性中,这可能会影响一个腺体的大小,即前列腺的控制。了解食物信号可以与特定受体结合并控制细胞功能是很重要的,这项资助将分析这些营养信号被感知的直接机制,通常与其他信号平衡,并发挥作用以揭示特定的基因目标。这将帮助其他科学家了解健康饮食的重要性,并帮助所有年龄段的人更健康、更长寿。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nuclear receptors and the Warburg effect in cancer.
- DOI:10.1002/ijc.29012
- 发表时间:2015-10-01
- 期刊:
- 影响因子:6.4
- 作者:Thorne JL;Campbell MJ
- 通讯作者:Campbell MJ
Epigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1/cip1) expression and function in non-malignant prostate cells.
- DOI:10.1093/nar/gkq875
- 发表时间:2011-03
- 期刊:
- 影响因子:14.9
- 作者:Thorne JL;Maguire O;Doig CL;Battaglia S;Fehr L;Sucheston LE;Heinaniemi M;O'Neill LP;McCabe CJ;Turner BM;Carlberg C;Campbell MJ
- 通讯作者:Campbell MJ
Epigenetic distortion to VDR transcriptional regulation in prostate cancer cells.
对前列腺癌细胞中VDR转录调控的表观遗传扭曲。
- DOI:10.1016/j.jsbmb.2012.10.002
- 发表时间:2013-07
- 期刊:
- 影响因子:4.1
- 作者:Singh, Prashant K.;Doig, Craig L.;Dhiman, Vineet K.;Turner, Bryan M.;Smiraglia, Dominic J.;Campbell, Moray J.
- 通讯作者:Campbell, Moray J.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher McCabe其他文献
Thyroid hormone and estrogen receptor expression in normal pituitary and nonfunctioning tumors of the anterior pituitary.
甲状腺激素和雌激素受体在正常垂体和无功能垂体前叶肿瘤中的表达。
- DOI:
10.1210/jcem.82.6.3969 - 发表时间:
1997 - 期刊:
- 影响因子:0
- 作者:
N. Gittoes;Christopher McCabe;J. Verhaeg;M. C. Sheppard;J. Franklyn - 通讯作者:
J. Franklyn
A Comparison of Four Software Programs for Implementing Decision Analytic Cost-Effectiveness Models
- DOI:
10.1007/s40273-017-0510-8 - 发表时间:
2017-05-09 - 期刊:
- 影响因子:4.600
- 作者:
Chase Hollman;Mike Paulden;Petros Pechlivanoglou;Christopher McCabe - 通讯作者:
Christopher McCabe
Su1025 - Cost-Effectiveness of Infliximab's Biosimilar CT-P13 Compared to Innovator Infliximab for the Management of Crohn's Disease
- DOI:
10.1016/s0016-5085(17)31702-x - 发表时间:
2017-04-01 - 期刊:
- 影响因子:
- 作者:
Candace L. Beilman;Christopher Ma;Christopher McCabe;Richard N. Fedorak;Brendan P. Halloran - 通讯作者:
Brendan P. Halloran
P591: Assessing the performance of automated HPO term extraction for deep phenotyping of patients receiving WES/WGS in a clinical diagnostic laboratory
- DOI:
10.1016/j.gimo.2023.100638 - 发表时间:
2023-01-01 - 期刊:
- 影响因子:
- 作者:
Kai Lee Yap;Anthony Wong;Sachleen Tuteja;Andrew Skol;Andy Drackley;Alexander Ing;Eleanor Hilton;Michael Carroll;Christopher McCabe;Sabah Kadri;Pamela Rathbun;Katrin Leuer;Joel Charrow - 通讯作者:
Joel Charrow
Thyroid Receptor a 1 and a 2 Mutations in Nonfunctioning Pituitary Tumors*
无功能垂体瘤中的甲状腺受体 a 1 和 a 2 突变*
- DOI:
- 发表时间:
1999 - 期刊:
- 影响因子:0
- 作者:
Christopher McCabe;N. Gittoes;M. C. Sheppard;J. Franklyn - 通讯作者:
J. Franklyn
Christopher McCabe的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher McCabe', 18)}}的其他基金
Xenon Futures: R&D For A Global Rare Event Observatory (Phase 2)
氙气期货:R
- 批准号:
ST/V001876/1 - 财政年份:2021
- 资助金额:
$ 36.42万 - 项目类别:
Research Grant
Novel strategies to fully exploit direct detection and LHC dark matter searches
充分利用直接探测和大型强子对撞机暗物质搜索的新策略
- 批准号:
ST/N004663/1 - 财政年份:2017
- 资助金额:
$ 36.42万 - 项目类别:
Fellowship
RE-ENGINEERING RADIOIODINE THERAPY FOR THE 21ST CENTURY
重新设计 21 世纪的放射性碘治疗
- 批准号:
MR/P000509/1 - 财政年份:2016
- 资助金额:
$ 36.42万 - 项目类别:
Research Grant
IMPROVING RADIOIODINE TREATMENT OF THYROID AND OTHER TUMOURS
改善甲状腺和其他肿瘤的放射性碘治疗
- 批准号:
MR/J001414/1 - 财政年份:2012
- 资助金额:
$ 36.42万 - 项目类别:
Research Grant
Methods for the Indirect estimation of health state utilities
健康状态效用的间接估计方法
- 批准号:
G0901490/1 - 财政年份:2010
- 资助金额:
$ 36.42万 - 项目类别:
Research Grant
New mechanisms of sodium iodide Symporter Repression
碘化钠同向转运蛋白抑制的新机制
- 批准号:
G0700064/1 - 财政年份:2007
- 资助金额:
$ 36.42万 - 项目类别:
Research Grant
相似国自然基金
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
- 批准号:82370798
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
- 批准号:82371634
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
- 批准号:82371028
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
- 批准号:82371651
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
- 批准号:82371801
- 批准年份:2023
- 资助金额:47.00 万元
- 项目类别:面上项目
精氨酸调控骨髓Tregs稳态在脓毒症骨髓功能障碍中的作用研究
- 批准号:82371770
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
亚低温调控颅脑创伤急性期神经干细胞Mpc2/Lactate/H3K9lac通路促进神经修复的研究
- 批准号:82371379
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
- 批准号:82372275
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
α-酮戊二酸调控ACMSD介导犬尿氨酸通路代谢重编程在年龄相关性听力损失中的作用及机制研究
- 批准号:82371150
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
mPFC-VTA-NAc多巴胺能投射调控丙泊酚麻醉—觉醒的机制研究
- 批准号:82371284
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
相似海外基金
Metabolism and Epigenetic Regulation are Couples in Transdifferentiation and Vascular Regeneration
代谢和表观遗传调控是转分化和血管再生的结合体
- 批准号:
10905167 - 财政年份:2023
- 资助金额:
$ 36.42万 - 项目类别:
Metabolic Symbiosis: Lactate as an Epigenetic Regulator and a Biofuel in Age-dependent Intervertebral Disc Degeneration
代谢共生:乳酸作为年龄依赖性椎间盘退变的表观遗传调节剂和生物燃料
- 批准号:
10704160 - 财政年份:2022
- 资助金额:
$ 36.42万 - 项目类别:
Early life aflatoxin B1 exposure and epigenetic programming in Nigerian Newborns
尼日利亚新生儿生命早期黄曲霉毒素 B1 暴露和表观遗传编程
- 批准号:
10518414 - 财政年份:2022
- 资助金额:
$ 36.42万 - 项目类别:
Epigenetic predisposition and pathogenic mechanisms of recessive dystrophic epidermolysis bullosa
隐性营养不良性大疱性表皮松解症的表观遗传倾向和致病机制
- 批准号:
10673176 - 财政年份:2022
- 资助金额:
$ 36.42万 - 项目类别:
Targeting integrated metabolic and epigenetic pathways in childhood ependymomas
针对儿童室管膜瘤的综合代谢和表观遗传途径
- 批准号:
10659244 - 财政年份:2022
- 资助金额:
$ 36.42万 - 项目类别:
Mechanisms of Target of Rapamycin Complex 1 Dependent Epigenetic Regulation
雷帕霉素复合物1依赖的表观遗传调控靶点机制
- 批准号:
10515603 - 财政年份:2022
- 资助金额:
$ 36.42万 - 项目类别:
Targeting integrated metabolic and epigenetic pathways in childhood ependymomas
针对儿童室管膜瘤的综合代谢和表观遗传途径
- 批准号:
10536996 - 财政年份:2022
- 资助金额:
$ 36.42万 - 项目类别:
Epigenetic predisposition and pathogenic mechanisms of recessive dystrophic epidermolysis bullosa
隐性营养不良性大疱性表皮松解症的表观遗传倾向和致病机制
- 批准号:
10453091 - 财政年份:2022
- 资助金额:
$ 36.42万 - 项目类别:
Early life aflatoxin B1 exposure and epigenetic programming in Nigerian Newborns
尼日利亚新生儿生命早期黄曲霉毒素 B1 暴露和表观遗传编程
- 批准号:
10706327 - 财政年份:2022
- 资助金额:
$ 36.42万 - 项目类别:
Mechanisms of Target of Rapamycin Complex 1 Dependent Epigenetic Regulation
雷帕霉素复合物1依赖的表观遗传调控靶点机制
- 批准号:
10653258 - 财政年份:2022
- 资助金额:
$ 36.42万 - 项目类别: